- Home
- PEPG vs BH Comparison
PEPG vs BH Comparison
Compare PEPG & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEPG | BH |
|---|---|---|
| Founded | 2018 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 1.2B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PEPG | BH |
|---|---|---|
| Price | $6.41 | $394.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $10.80 | N/A |
| AVG Volume (30 Days) | ★ 829.9K | 71.0K |
| Earning Date | 02-26-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.91 |
| Revenue | N/A | ★ $386,507,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $595.11 |
| Revenue Growth | N/A | ★ 6.87 |
| 52 Week Low | $0.88 | $195.05 |
| 52 Week High | $7.80 | $483.60 |
Technical Indicators
Market Signals| Indicator | PEPG | BH |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 48.32 |
| Support Level | $4.25 | $397.99 |
| Resistance Level | $7.14 | $419.46 |
| Average True Range (ATR) | 0.54 | 21.13 |
| MACD | 0.19 | -3.38 |
| Stochastic Oscillator | 84.05 | 56.34 |
Price Performance
Historical ComparisonAbout PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.